BL Pharmtech Corp. (KOSDAQ:065170)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,720.00
+625.00 (29.83%)
At close: Sep 11, 2026

BL Pharmtech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5,7897,1513,86410,6075,02421,752
Short-Term Investments
00-2,6005001,000
Cash & Short-Term Investments
5,7897,1513,86413,2075,52422,752
Cash Growth
52.22%85.08%-70.74%139.10%-75.72%83.78%
Accounts Receivable
834.76762.27857.11,0119,20810,364
Other Receivables
21.9842.68126.4972.821,863120.06
Receivables
887.94836.15983.61,08311,07111,097
Inventory
298.3510.571,6331,89314,7547,765
Prepaid Expenses
8.7511.82116.73213.11353.3760.02
Other Current Assets
100.9973.73340.05518.21909.22627.19
Total Current Assets
7,0858,5846,93716,91532,61242,301
Property, Plant & Equipment
3,6373,8084,1292,87842,33942,899
Long-Term Investments
5,0584,78813,88422,05617,01126,439
Goodwill
--0-0-8,00013,151
Other Intangible Assets
67.175.87221.15548.991,1701,538
Long-Term Accounts Receivable
-45.31151.090--
Long-Term Deferred Tax Assets
----1,5321,679
Long-Term Deferred Charges
-----3.94
Other Long-Term Assets
820.59791.4211,0312,4031,0232,330
Total Assets
17,07118,19536,45844,802103,687130,341

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
275.76314.52402.831,0782,8457,254
Accrued Expenses
101.5791.653.5462.56555.77447.08
Short-Term Debt
3,0793,1723,875-29,0927,817
Current Portion of Long-Term Debt
-1,300-1,4101,96712,804
Current Portion of Leases
371.14448.34390.6361.19504.13422.67
Other Current Liabilities
3,6383,6671,9075,05414,0158,255
Total Current Liabilities
7,4658,9946,6297,96548,97937,000
Long-Term Debt
--1,3002,34310,73920,694
Long-Term Leases
0.77121.34534.77148.36404156.55
Pension & Post-Retirement Benefits
876.46784.29609.93507.072,0882,770
Long-Term Deferred Tax Liabilities
250.17250.17202.8252.17310.39360
Other Long-Term Liabilities
128.88117.952,9141,78784.293,852
Total Liabilities
8,72210,26812,19013,00262,60464,832

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
13,95713,3424,44944,48544,48544,485
Additional Paid-In Capital
95,08793,713102,524101,17599,995100,007
Retained Earnings
-101,338-100,206-68,625-102,983-95,790-82,200
Treasury Stock
-9.35-9.35-1.69-1.69-1.69-1.69
Comprehensive Income & Other
627.641,057-14,099-11,257-14,888-3,794
Total Common Equity
8,3247,89624,24731,41933,80058,497
Minority Interest
25.1231.721.56380.357,2827,013
Shareholders' Equity
8,3497,92724,26831,79941,08265,510
Total Liabilities & Equity
17,07118,19536,45844,802103,687130,341

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3,4515,0426,1004,26242,70641,894
Net Cash (Debt)
2,3382,110-2,2368,945-37,182-19,142
Net Cash Growth
------
Net Cash Per Share
87.4579.07-83.85335.15-1393.08-726.73
Filing Date Shares Outstanding
26.7626.688.8926.6926.6926.69
Total Common Shares Outstanding
26.7626.682.6726.6926.6926.69
Working Capital
-380.53-410.36308.538,951-16,3675,301
Book Value Per Share
311.10295.959088.311177.161266.372191.67
Tangible Book Value
8,2577,82024,02530,87024,63043,807
Tangible Book Value Per Share
308.59293.119005.411156.59922.801641.29
Land
-2,5382,5381,8129,5539,553
Buildings
-2,2972,2971,87721,72621,726
Machinery
-402.84402.84396.0416,83515,761
Construction In Progress
-----32.85